![Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway | Oncogene Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41388-018-0252-x/MediaObjects/41388_2018_252_Fig1_HTML.jpg)
Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway | Oncogene
![Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling](https://pubs.acs.org/cms/10.1021/acs.jcim.1c00301/asset/images/large/ci1c00301_0001.jpeg)
Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling
![Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842818301021-gr1.jpg)
Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect
Structural insights and binding analysis for determining the molecular bases for programmed cell death protein ligand-1 inhibition - MedChemComm (RSC Publishing)
![Heterogeneity of programmed death-ligand 1 expression and infiltrating lymphocytes in paired resected primary and metastatic non-small cell lung cancer | Modern Pathology Heterogeneity of programmed death-ligand 1 expression and infiltrating lymphocytes in paired resected primary and metastatic non-small cell lung cancer | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41379-021-00903-w/MediaObjects/41379_2021_903_Fig1_HTML.png)
Heterogeneity of programmed death-ligand 1 expression and infiltrating lymphocytes in paired resected primary and metastatic non-small cell lung cancer | Modern Pathology
![The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity | The Journal of Immunology The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/193/8/3835/F1.large.jpg)
The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity | The Journal of Immunology
![Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy | Scientific Reports Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-79419-3/MediaObjects/41598_2020_79419_Fig1_HTML.png)
Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy | Scientific Reports
![The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development | Science Advances The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development | Science Advances](https://www.science.org/cms/asset/f98c5f65-dd9e-4dc1-a761-dc42857c3519/keyimage.gif)
The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development | Science Advances
![Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt-2018-0110/asset/images/medium/figure2.gif)
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
![Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/958739e4-32fb-4592-a516-73abe8293179/gr1.jpg)
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews
![Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism in: Endocrine Connections Volume 7 Issue 5 (2018) Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism in: Endocrine Connections Volume 7 Issue 5 (2018)](https://ec.bioscientifica.com/view/journals/ec/7/5/images/EC-18-0079fig1.jpeg)
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism in: Endocrine Connections Volume 7 Issue 5 (2018)
![Cancers | Free Full-Text | Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases Cancers | Free Full-Text | Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases](https://www.mdpi.com/cancers/cancers-13-03034/article_deploy/html/images/cancers-13-03034-g001.png)
Cancers | Free Full-Text | Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases
![Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8b80cb51-668a-4eeb-8daf-d878f2b041f4/gr2.jpg)
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews
![Cancers | Free Full-Text | Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases Cancers | Free Full-Text | Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases](https://www.mdpi.com/cancers/cancers-13-03034/article_deploy/html/images/cancers-13-03034-g003.png)